Dash Bio

Dash Bio is working to revolutionize clinical bioanalysis by leveraging AI and robotics to accelerate drug development, delivering assays up to 10 times faster than industry standards for clinical trials and GLP (Good Laboratory Practices) studies. While AI has transformed drug discovery, development remains hindered by manual processes—Dash Bio aims to automate critical steps to reduce costs and time to market without compromising quality. Its modern platform combines robotics and AI to seamlessly integrate automation, quality, and regulatory compliance, enhancing efficiency and outcomes in clinical bioanalysis.